Blockade of macrophage colony-stimulating factor reduces macrophage proliferation and accumulation in renal allograft rejection

被引:66
作者
Jose, MD [1 ]
Le Meur, Y [1 ]
Atkins, RC [1 ]
Chadban, SJ [1 ]
机构
[1] Monash Med Ctr, Dept Nephrol, Melbourne, Vic, Australia
关键词
acute rejection; c-fms; kidney; macrophage proliferation; M-CSF;
D O I
10.1034/j.1600-6143.2003.00068.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Macrophage accumulation within an acutely rejecting allograft occurs by recruitment and local proliferation. To determine the importance of M-CSF in driving macrophage proliferation during acute rejection, we blocked the M-CSF receptor, c-fms, in a mouse model of acute renal allograft rejection. C57BL/6 mouse kidneys (allografts, n = 20) or BALB/c kidneys (isografts, n = 5) were transplanted into BALB/c mice. Anti-c-fms antibody (AFS98) or control Ig (50 mg/kg/day, i.p.) was given daily to allografts from days 0-5. All mice were killed day 6 postoperatively. Expression of the M-CSF receptor, c-fms, was restricted to infiltrating CD68(+) macrophages. Blockade of c-fms reduced proliferating (CD68(+)/BrdU(+)) macrophages by 82% (1.1 v 6.2%, p < 0.001), interstitial CD68(+) macrophage accumulation by 53% (595 v 1270/mm(2), p < 0.001), and glomerular CD68(+) macrophage accumulation by 71% (0.73 V 2.48 CD68(+) cells per glomerulus, p < 0.001). Parameters of T-cell involvement (intragraft CD4(+), CD8(+) and CD25(+) lymphocyte numbers) were not affected. The severity of tubulointerstitial rejection was reduced in the treatment group as shown by decreased tubulitis and tubular cell proliferation. Macrophage proliferation during acute allograft rejection is dependent on the interaction of M-CSF with its receptor c-fms. This pathway plays a significant and specific role in the accumulation of macrophages within a rejecting renal allograft.
引用
收藏
页码:294 / 300
页数:7
相关论文
共 44 条
[1]   THE ROLE OF INDIRECT RECOGNITION IN INITIATING REJECTION OF SKIN-GRAFTS FROM MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II-DEFICIENT MICE [J].
AUCHINCLOSS, H ;
LEE, R ;
SHEA, S ;
MARKOWITZ, JS ;
GRUSBY, MJ ;
GLIMCHER, LH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (08) :3373-3377
[2]  
Bingisser RM, 1998, J IMMUNOL, V160, P5729
[3]  
Brown FG, 1999, CLIN EXP IMMUNOL, V118, P329
[4]   Beneficial effects of targeting CCR5 in allograft recipients [J].
Gao, W ;
Faia, KL ;
Csizmadia, V ;
Smiley, ST ;
Soler, D ;
King, JA ;
Danoff, TM ;
Hancock, WW .
TRANSPLANTATION, 2001, 72 (07) :1199-1205
[5]   Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection [J].
Gao, W ;
Topham, PS ;
King, JA ;
Smiley, ST ;
Csizmadia, V ;
Lu, B ;
Gerard, CJ ;
Hancock, WW .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (01) :35-44
[6]  
Grandaliano G, 1997, TRANSPLANTATION, V63, P414, DOI 10.1097/00007890-199702150-00015
[7]  
Grau V, 1998, CELL TISSUE RES, V291, P117
[8]  
Grau V, 2000, SCAND J IMMUNOL, V51, P435
[9]  
Grimm PC, 1999, J AM SOC NEPHROL, V10, P1582
[10]   Met-RANTES reduces vascular and tubular damage during acute renal transplant rejection:: blocking monocyte arrest and recruitment [J].
Gröne, HJ ;
Weber, C ;
Weber, KSC ;
Gröne, EF ;
Rabelink, T ;
Klier, CM ;
Wells, TNC ;
Proudfoot, AE ;
Schlöndorff, D ;
Nelson, PJ .
FASEB JOURNAL, 1999, 13 (11) :1371-1383